Show simple item record

dc.creatorFeuerstein, GZ
dc.creatorMansfield, MA
dc.creatorLelkes, PI
dc.creatorAlesci, S
dc.creatorMarcinkiewicz, C
dc.creatorButlin, N
dc.creatorSternberg, M
dc.date.accessioned2020-12-10T18:03:27Z
dc.date.available2020-12-10T18:03:27Z
dc.date.issued2020-01-01
dc.identifier.issn1178-2013
dc.identifier.issn1178-2013
dc.identifier.doihttp://dx.doi.org/10.34944/dspace/4262
dc.identifier.other33116489 (pubmed)
dc.identifier.urihttp://hdl.handle.net/20.500.12613/4280
dc.description.abstract© 2020 Feuerstein et al. Background: There is a dire need for rapid diagnostic tests of high sensitivity, efficiency, and point-of-test reporting capability to mitigate lethal viral epidemic outbreaks. Purpose: To develop a new operating system within the lateral flow assay (LFA) format for Ebola virus (EBOV), based on fluorescent nanodiamond particles (FNDP) nitrogen vacancy (NV) emitting near-infrared (NIR) light. Specifically, we aimed to detail technical issues and the feasibility of mobilizing FNDP-NV on nitrocellulose membranes (NCM) and capturing them at test and control lines. Methods: FNDP-NV-200nm, 400nm or 800nm were linked to anti-EBOV glycoprotein (GP) monoclonal antibodies (mAb) and tested for LFA performance by monitoring NIR emissions using an in vivo imaging system or optoelectronic device (OED). Anti-EBOV recombinant glycoprotein (GP) humanized mAb c13C6 was linked to FNDP-NV-200nm for the mobile phase; and a second anti-GP mouse mAb, 6D8, was printed on NCM at the test line. Goat anti-human IgG (GAH-IgG) served as a nonspecific antibody for conjugated FNDP-NV-200nm at the control line. Results: FNDP-NV-200nm-c13C6 specifically and dose-dependently bound to recombinant EBOV GP in vitro and was effectively captured in a sandwich configuration at the test line by mAb 6D8. FNDP-NV-200nm-c13C6 was captured on the control line by GAH-IgG. The OED quantitative analysis of NIR (obtained in less than 1 minute) was further validated by an in vivo imaging system. Conclusion: FNDP-NV-200nm performance as a reporter for EBOV GP rapid diagnostic tests suggests an opportunity to replace contemporary visual tests for EBOV GP and other highly lethal viral pathogens. Mobile, battery-operated OED adds portability, quantitative data, rapid data collection, and point-of-test reporting capability. Further development of FNDP-NV-200nm within a LFA format is justified.
dc.format.extent7583-7599
dc.language.isoen
dc.relation.haspartInternational journal of nanomedicine
dc.relation.isreferencedbyInforma UK Limited
dc.rightsCC BY-NC
dc.rights.urihttps://creativecommons.org/licenses/by-nc/3.0/
dc.subjectEbola virus
dc.subjectdiagnostic lateral flow test
dc.subjectLFA
dc.subjectopto-electronic reader
dc.subjectOER
dc.subjectanti-EBOV antibodies
dc.subjectnitrocellulose membranes
dc.subjectfluidics technology
dc.titleThe Use of Near-Infrared Light-Emitting Fluorescent Nanodiamond Particles to Detect Ebola Virus Glycoprotein: Technology Development and Proof of Principle
dc.typeArticle
dc.type.genreJournal Article
dc.relation.doi10.2147/IJN.S261952
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.creator.orcidLelkes, Peter|0000-0003-4954-3498
dc.date.updated2020-12-10T18:03:22Z
refterms.dateFOA2020-12-10T18:03:28Z


Files in this item

Thumbnail
Name:
The Use of Near-Infrared Light ...
Size:
10.30Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

CC BY-NC
Except where otherwise noted, this item's license is described as CC BY-NC